[1]
Z. N. Zheng, X. H. Shen, X. B. Ye, T. Li, and J. Guo, “Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates”, World J Oncol, vol. 17, no. 2, pp. 129–142, Jan. 2026, doi: 10.14740/wjon2718.